Goldfarb Branham LLP is investigating whether the Board of Directors of Gerber Scientific (NYSE: GRB) violated shareholder protection laws in connection with the buyout by Vector Capital for $11.00 per share. If you are a Gerber shareholder – or have knowledge about this transaction – you are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or firstname.lastname@example.org. “While the merger agreement provides opportunity to shop for superior proposals through July 25, 2011, there is no guarantee that this process will result in a better offer,” securities lawyer Hamilton Lindley said. “Our potential class action lawsuit seeks to ensure that the Gerber Board of Directors maximizes value for investors in this takeover.” Goldfarb Branham has significant experience representing individual and institutional investors. Lawyers at the firm have represented investors in over 100 shareholder class action cases. A firm securities lawyer, Hamilton Lindley, can be reached at email@example.com or 877-583-2855 to discuss the impact of this buyout on Gerber investors.
Gerber Scientific (NYSE:GRB) hit a new 52-week high Friday as it is currently trading at $11.18, above its previous 52-week high of $11.15 with 9,721 shares traded as of 10:16 a.m. ET. Average volume has been 492,800 shares over the past 30 days.
Shares of Gerber Scientific (NYSE:GRB) have taken a tremendous swing upward. The stock is trading at $10.87 as of 9:31 a.m. ET, 33.9% above Friday's closing price of $8.12. Volume is at 11.6 million, 217.1 times the daily average of 53,200.
Shares of Gerber Scientific (NYSE:GRB) have taken a tremendous swing upward. The stock is trading at $9.47 as of 9:56 a.m. ET, 20.9% above Wednesday's closing price of $7.83. Volume is at 27,319, 0.4 times the daily average of 61,900.